Work

Abstract 1736: Novel fourth-generation ALK inhibitors targeting compound mutations in ALK-positive cancers

Year: 2025
Type: conference-abstract
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4409624456
Cites:
Cited by:
Related to: 10